Clinical trial opportunity for newly diagnosed COVID-19 patients

Volunteers Within 7 Days of Symptoms Onset Needed For COVID-19 Research

We are seeking patients with COVID-19-like symptoms to participate in a clinical trial “Modulation of gut microbiota with NBT-NM108 as an early treatment for suspected or confirmed COVID-19 patients(COVGUT20)”. Participants will be randomly assigned to the treatment or control group. Those in the treatment group will take the Investigational New Drug up to 4 times a day for 28 days. All participants will evaluate their COVID-19 symptoms, and provide up to 4 stool samples during the 56-day study.

You may be eligible if you:

  • Are a Florida or New Jersey resident
  • Are between 18 and 79 years old
  • Have COVID-19-like symptoms for less than 7 days and have been tested for COVID-19

This clinical trial is sponsored by Notitia Biotechnologies Company. For more information, please visit notitiabio.com and clinicaltrials.gov

{{ successMessage }} Thank you for registering. Within a few seconds you will be forwarded to a pre-screening questionnaire.
{{ failureMessage }} Your registration could not be processed. Please refresh the page and try again.

If you are interested, please sign up below to receive a preliminary screening survey.

Please enter a valid email address.
Please agree to the privacy policy.

Daily COVID-19 symptom monitoring

Medical support and guidance during the trial

Home-based trial, no travel or clinical visit is needed

Compensated for providing fecal samples

Clinical trial opportunity for newly diagnosed COVID-19 patients